Achilles stock went into this earnings print on a strong run, with double digit gains over the past month. Yet the real story today sits in the income statement. The chemicals group delivered Q1 2027 basic earnings per share of ¥74.79 on revenue of ¥21,361m, a sharp step up from recent quarterly profit levels. That profit rebound feeds into trailing earnings that support an 8x P/E, which screens as low compared with both the wider Japan market and the domestic chemicals sector. The gap between that valuation and the share price strength is what investors will focus on next.

Is Achilles stock flashing a rare value opportunity at 8x P/E, or is that low multiple pointing to a deeper problem behind the recent earnings swing? Compare the current share price to intrinsic value in the valuation analysis for Achilles.

Q1 2027 Earnings Summary

• Revenue (Q1 2027 vs. Q1 2026): ¥21,361m vs. ¥18,378m (higher year on year)
• Net Income (Excl. Extra Items, Q1 2027 vs. Q1 2026): ¥1,022m vs. ¥246m (very large year on year increase)
• Basic EPS (Q1 2027 vs. Q1 2026): ¥74.79 vs. ¥18.00 (very large year on year increase)
• Trailing Net Profit Margin (Latest 12 months vs. Prior 12 months): 3.4% vs. 0.9% (higher profitability ratio)

If you prefer clear charts to scanning detailed earnings tables and raw data, view Achilles' overall financial profile and valuation in the company report for Achilles.

Achilles earnings tilt sentiment toward cautious optimism

For investors leaning positive on Achilles, the latest quarter gives some support. Revenue in Q1 2027 sits ahead of Q1 2026, and net income excluding extra items and basic EPS are both much higher year on year. That improvement also feeds into a higher trailing net profit margin of 3.4% compared with 0.9% in the prior 12 months. For a diversified industrial and consumer business, this points to better earnings conversion across several segments. This fits a steady, mildly constructive view on the core operations.

Profit rebound still leaves room for doubt

The other side of the argument is that Achilles is coming off a low profitability base. A trailing net margin of 3.4% is still modest for a chemicals and materials group, even after the strong Q1 2027 EPS print. The large year on year jump in net income also raises the question of how repeatable these drivers are across different end markets such as construction, autos and consumer products. The mixed, conglomerate style profile remains exposed to segment swings, so recent progress does not remove execution or cycle risk.

After a 9.5% annual decline in earnings and recent share price volatility, it is worth asking if Achilles faces deeper structural pressures. Review our risk analysis for Achilles which shows 2 important warning signs

Stay Ahead Of The Next Move In Achilles

If Achilles now sits on your radar after the sharp Q1 2027 earnings swing and an 8x P/E that looks low compared with peers, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch for a more attractive entry point. Once you are invested, use the Portfolio Command Center to cut through market noise and focus on the most important updates to your holdings. For a broader view, tap into crowd insights with the Community and see how other investors are reacting to the latest Achilles numbers. This combination helps you surface potential catalysts or risks early and stay a step ahead of the wider market.

Seeking Alternatives Beyond Achilles Stock

Fresh ideas can move fast. Some stocks are building quiet breakout momentum while others get caught before the crowd reacts. Scan these focused shortlists while it matters and consider acting early based on your own research.

• Spot potential breakout stability plays by reviewing curated list of solid balance sheet and fundamentals stocks (40 results) before others notice their steady fundamentals and price action.
• Track stronger income streams in a rising rate environment by checking out hand picked 43 dividend fortresses that could help keep cash flows coming while prices are still settling.
• Look for under the radar opportunities by scanning carefully filtered 63 high quality undiscovered gems that may offer fresh momentum before wider attention changes valuations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.